Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.8M Sell
21,760
-25
-0.1% -$2.93K 0.94% 35
2026
Q1
$2.62M Sell
21,785
-26,181
-55% -$3.02M 1.14% 25
2025
Q4
$5.05M Buy
47,966
+4,780
+11% +$449K 2.17% 15
2025
Q3
$3.62M Buy
43,186
+10,842
+34% +$893K 1.73% 19
2025
Q2
$2.56M Sell
32,344
-5,202
-14% -$413K 1.43% 20
2025
Q1
$3.37M Buy
37,546
+13,002
+53% +$1.21M 2.23% 13
2024
Q4
$2.44M Sell
24,544
-853
-3% -$87.9K 1.8% 15
2024
Q3
$2.88M Buy
25,397
+5,593
+28% +$664K 1.89% 14
2024
Q2
$2.45M Buy
19,804
+10,872
+122% +$1.4M 2.41% 13
2024
Q1
$1.18M Buy
8,932
+5,217
+140% +$643K 1.39% 11
2023
Q4
$405K Sell
3,715
-54
-1% -$5.61K 0.43% 10
2023
Q3
$388K Buy
3,769
+805
+27% +$86.8K 0.44% 10
2023
Q2
$342K Sell
2,964
-3,360
-53% -$381K 0.39% 9
2023
Q1
$673K Sell
6,324
-13,251
-68% -$1.43M 0.84% 9
2022
Q4
$2.17M Sell
19,575
-27,819
-59% -$2.84M 2.68% 7
2022
Q3
$4.08M Buy
47,394
+2,760
+6% +$246K 4.18% 6
2022
Q2
$4.07M Sell
44,634
-6,729
-13% -$597K 4.13% 6
2022
Q1
$4.21M Buy
+51,363
New +$4.05M 3.91% 6

Other funds holding MRK

Harper Investing's MRK Position: Q2 2026 in Review

Harper Investing reduced its Merck (MRK) stake by 0.11% in Q2 2026, selling an estimated $2.93K and leaving 21,760 shares worth $2.8M. The position accounts for 0.94% of the portfolio, ranked #35.

Harper Investing first reported a position in MRK in Q1 2022 and has held it in 18 quarters since. The position peaked at $5.05M in Q4 2025. 1,495 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Harper Investing held 21,760 shares of Merck worth $2.8M as of Q2 2026.
  • Harper Investing sold 25 Merck shares in Q2 2026, an estimated $2.93K.
  • Merck made up 0.94% of Harper Investing's portfolio in Q2 2026, its #35 holding.
  • Harper Investing first reported a position in Merck in Q1 2022 and has held it in 18 quarters since.
  • Harper Investing's Merck position peaked at $5.05M in Q4 2025.
  • 1,495 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Harper Investing's 13F filing for Q2 2026, filed 22 Jul 2026.